San Francisco-based food company bringing pork alternative to stores
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience.
Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Generate Key Takeaways
The Brief
A new pork alternative is coming to San Francisco grocery stores.
The creator of the pork alternative, Mission Barns, is also bringing bacon to stores this year.
KTVU got an inside look at the company's test kitchen.
SAN FRANCISCO - A San Francisco-based food company is the first in the nation to bring its cell-cultivated pork to grocery stores this year. KTVU got an inside look—and a taste test—at the company's kitchen.
Inside the Mission Barns test kitchen in San Francisco, Chef Daniel Ryan is cooking up something new.
"The meatball will be our first product," Daniel Ryan, Director of Product Development, told KTVU.
The meatball in question is composed of a cell-cultivated pork alternative, made Italian-style.
In March, Mission Barns received federal approval to bring its cell-cultivated pork directly to consumers, a process that took three years.
So what's the difference between Mission Barns' pork and what we've been consuming? They say, not much.
"The cell material is real pork fat, and it acts as a portion of the fat, just like it would in real meatballs," Ryan said. "Our product has an amazing record in terms of food safety. That's a result of some of the handling of the cellular material. And the rest is comprised of plant-based material."
Meet Dawn
The backstory
This pig is named Dawn. She's just like any other pig. But her cells can be turned into pork products in the Mission Barns lab again and again. Allowing dawn to live out her life in a sanctuary in upstate New York, all while her cells help make food.
The Mission Barns team says their product is a more sustainable option, while still tasting good.
"Probably my favorite attribute of it, is that after you finished chewing it and swallowing it, the coating it leaves on your mouth," Saam Shahrojhi, Chief Technology Officer, Mission Barns said.
The team is also planning to release bacon this year, which they hope will make a big splash.
"The Bay Area is the hub of innovation so being able to bring my skillset to a company like this and produce food that could feed the masses one day is a very exciting opportunity," Ryan told KTVU.
If you are interested in trying Mission Barns products, they will be available at Sprouts and Fiorella, coming soon.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Gainsight Founder Nick Mehta Names Hand-Picked Successor Chuck Ganapathi as CEO
From SaaS to RaaS: Gainsight Ushers in Agentic Era of Customer Retention SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Gainsight, the retention engine powering the world's most customer-centric companies, today announced the promotion of Chuck Ganapathi to Chief Executive Officer. After 13 years as CEO, Nick Mehta will step into a new role as Board Member and Special Advisor to the CEO. 'Chuck has been transformational to Gainsight,' said Mehta. 'Under his leadership, we have launched our CustomerOS product strategy, accelerated our AI transformation, spearheaded key acquisitions, and strengthened our human-first culture and the Pulse community. He's the right person to guide Gainsight into the agentic era.' Ganapathi, previously Gainsight's President and COO, has over 25 years of experience in CRM, AI, and enterprise software innovation, including leadership roles at Salesforce, Siebel, and 'Nick Mehta created a category, built a beloved brand, and led with heart and conviction,' said John Stalder, Managing Director at Vista Equity Partners and Gainsight board member. 'As Gainsight enters this next chapter, we're excited for the future with Chuck. He brings the perfect blend of strategy and operational excellence to extend Gainsight's leadership and accelerate its vision for retention-as-a-service.' The Next Chapter: Retention-as-a-Service (RaaS) Retention has become existential for SaaS companies. In a world where software is commoditized overnight and switching costs are near zero, every customer relationship is critical to survival. Gainsight has deliberately transformed into an AI-first company to lead this shift, pioneering Retention-as-a-Service: a new operating model for post-sales, powered by Atlas AI Agents and a unified CustomerOS platform. 'As OpenAI CEO Sam Altman said, we're entering the 'fast fashion era of SaaS,' where outcomes are the only real moat,' said Ganapathi. 'That means you have to treat every customer like your best customer, and that's what Gainsight is designed for. Nick has been a great friend for 25 years, and I'm grateful for his leadership in the first chapter of Gainsight. I'm honored to carry the torch into Gainsight's next chapter and thankful for our team and the broader Customer Success community.' Product & Platform Momentum Since joining the company 18 months ago, Ganapathi has led the company's transformation, expanded the CustomerOS platform, and accelerated growth through its agentic product roadmap. Recent highlights: Tripling down on agentic innovation with the acquisitions of Staircase AI, UpdateAI, and ModerateKit. Early traction for Renewal AI, the first autonomous agent in the Atlas family, is already in pilot with charter clients and hundreds of organizations on the waitlist. Breakout growth with 4x ARR expansion for Staircase AI and a record-breaking quarter for Skilljar, now one of Gainsight's biggest product lines. Enterprise momentum with iconic new wins and expansions at Adobe, Docusign, and a landmark rollout at SAP, the largest in Gainsight's history. Gainsight is also launching a new version of its flagship CS product, now with natively embedded agentic capabilities powered by Staircase AI—making Gainsight the first platform to bring AI agents directly into the core workflows of Customer Success teams. Continued Community Commitment Over the past decade, Gainsight has become the home for one of the largest professional communities in enterprise software—with six books published and more than 30,000 attendees across Gainsight's global CxO and Pulse events. This transition doubles down on what has always set Gainsight apart: a human-first culture, deep community roots, and a relentless focus on outcomes. 'All of the Gainsight you love—Pulse, our thought leadership, our platform—is only getting stronger,' added Mehta. 'I'm proud of what we've built together, deeply grateful to our team and community, and excited to keep supporting Gainsight's future on the board.' To learn more about Gainsight's vision for the future of agentic AI, watch the latest episode of the [Un]Churned podcast and visit About GainsightGainsight is the retention engine behind the world's most customer-centric companies. The Gainsight CustomerOS platform orchestrates the customer journey from onboarding to outcomes. More than 2,000 companies trust Gainsight's applications and AI agents to drive learning, adoption, community connection, and success for their customers. Learn more at Media ContactJocelynn StidhamPR for while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Wire
4 minutes ago
- Business Wire
Vittori to Unveil First Hypercar in Miami on October 4, 2025
MIAMI--(BUSINESS WIRE)--Vittori, a new hypercar company, will unveil its first model on October 4, 2025 in Miami at a private, invite-only event. The running concept car was developed in collaboration with Pininfarina, the legendary Italian studio behind icons for Ferrari and Maserati. Vittori will unveil its first hypercar in Miami on Oct 4, 2025—developed with Pininfarina, with titanium 3D-printed components and a hybrid powertrain targeting 1,100 hp. Media invites: press@ Share The concept previews Vittori's engineering approach: AI-assisted design, lightweight construction with titanium 3D-printed components and advanced composites. Power comes from a hybrid system pairing a high-performance internal-combustion engine with electric motors and a high-voltage battery pack, targeting 1,100 horsepower. The car on display is a running concept; production specifications may change, and timing will be announced as development progresses. 'Partnering with Pininfarina lets us combine timeless design with modern manufacturing,' said Carlos Cruz, founder and CEO of Vittori. 'This concept shows the direction of our first production car—driver-focused, shaped by AI, and built with uncompromising materials.' Attendance at the Miami unveiling is by invitation only. Media and qualified buyers may request an invitation at press@ Images and b-roll will be available following the event. About Vittori Vittori is a high-performance automaker building next-generation hyper vehicles that blend AI-assisted design, additive manufacturing, and race-bred engineering. Learn more at Forward-Looking Statements This release contains forward-looking statements, including expected vehicle performance and development milestones. Actual results may differ due to engineering, certification, supply chain, and other factors. Vittori undertakes no obligation to update these statements. Trademarks Ferrari and Maserati are trademarks of their respective owners. Pininfarina is a trademark of Pininfarina S.p.A. Use here is for identification only and does not imply endorsement.
Yahoo
33 minutes ago
- Yahoo
Novavax Strengthens Position with Vaccine Approval and Sanofi Partnership
Novavax, Inc. (NASDAQ:NVAX) is one of the 11 Best Short Squeeze Stocks to Buy Now. The company's non-mRNA COVID-19 vaccine is approved, strengthening its Sanofi partnership. A closeup of a vial of the biotechnology company's vaccines. Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company focused on recombinant protein-based vaccines using nanoparticle and Matrix-M adjuvant technology. The Maryland-based company has an approved COVID-19 vaccine, Nuvaxovid, which is being commercialized globally through partnerships, including a major agreement with Sanofi. Currently, the company is expanding its product reach for emerging infectious disease prevention. On May 19, 2025, Novavax, Inc. (NASDAQ:NVAX) announced that it had received U.S. FDA Biologics License Application (BLA) approval for Nuvaxovid™, a recombinant protein-based, non-mRNA COVID-19 vaccine. The BLA approval triggered a $175 million milestone payment from Sanofi. Later, for select markets, Novavax, Inc. (NASDAQ:NVAX) has completed the transition of Nuvaxovid™ commercial leadership to Sanofi for the 2025-2026 COVID-19 vaccination season. By Q4 2025, the marketing authorization transfers to Sanofi for the U.S. and EU markets will be completed, which will result in an additional $50 million in combined milestones. Additionally, in June 2025, initial cohort data from a Phase 3 trial for Novavax's COVID-19-Influenza-Combination (CIC) and stand-alone influenza vaccine candidates showed significant immune responses, with T-cell responses numerically higher than the comparator Fluzone HD arm. With the results suggesting increased duration of protection, the company is discussing potential partnerships for these late-stage assets. Novavax, Inc. (NASDAQ:NVAX)'s 29.12% short float signals heavy bearish sentiment. With it, the company is up on the stage for a sharp rebound with slight positive market sentiment shifts. While we acknowledge the potential of NVAX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best REIT Stocks to Buy Right Now and 10 Stocks with Huge Catalysts on the Horizon Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
